Literature DB >> 15526982

Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing gnRH agonist versus antagonist protocols for ovarian hyperstimulation.

Barbara Sonntag1, Ludwig Kiesel, Eberhard Nieschlag, Hermann M Behre.   

Abstract

PURPOSE: To study the association of inhibin B with ovarian response to FSH stimulation, applying either GnRH agonist or antagonist.
METHODS: In a prospective randomized controlled trial, 46 patients undergoing COH received either triptorelin (group I, n = 15) or ganirelix (group II, n = 31). Parameters of follicular response and inhibin B serum levels were assessed.
RESULTS: Inhibin B before FSH stimulation was significantly lower in group I than group II. The FSH stimulation phase was significantly longer in group I than group II, and the total FSH dose was significantly higher with a comparable number of retrieved oocytes. Day 1 inhibin B in group I, but not group II, was significantly correlated with the number of large ovarian follicles and retrieved oocytes. In group II, but not group I, inhibin B on day 1 was inversely correlated with the daily and total FSH dose as well as FSH stimulation duration.
CONCLUSIONS: The association of inhibin B serum levels with parameters of follicular response in COH is different in patients assigned to GnRH agonist vs. antagonist treatment protocols.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526982      PMCID: PMC3455182          DOI: 10.1023/b:jarg.0000042010.86102.03

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  24 in total

Review 1.  Ovarian reserve testing and the use of prognostic models in patients with subfertility.

Authors:  A Bukman; M J Heineman
Journal:  Hum Reprod Update       Date:  2001 Nov-Dec       Impact factor: 15.610

2.  Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.

Authors: 
Journal:  Hum Reprod       Date:  2001-04       Impact factor: 6.918

3.  Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.

Authors:  J Peñarrubia; J Balasch; F Fábregues; F Carmona; R Casamitjana; V Moreno; J M Calafell; J A Vanrell
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918

4.  Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.

Authors:  G Borm; B Mannaerts
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918

Review 5.  An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis.

Authors:  J K Findlay
Journal:  Biol Reprod       Date:  1993-01       Impact factor: 4.285

6.  Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome.

Authors:  M Creus; J Peñarrubia; F Fábregues; E Vidal; F Carmona; R Casamitjana; J A Vanrell; J Balasch
Journal:  Hum Reprod       Date:  2000-11       Impact factor: 6.918

Review 7.  Regulation of follicle development and novel approaches to ovarian stimulation for IVF.

Authors:  N Smacklon; B C Fauser
Journal:  Hum Reprod Update       Date:  2000 Jul-Aug       Impact factor: 15.610

8.  Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle.

Authors:  A Dzik; G Lambert-Messerlian; V M Izzo; J B Soares; J A Pinotti; D B Seifer
Journal:  Fertil Steril       Date:  2000-12       Impact factor: 7.329

9.  Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone.

Authors:  T Eldar-Geva; D M Robertson; N Cahir; N Groome; M P Gabbe; V Maclachlan; D L Healy
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

10.  Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment.

Authors:  F W Casper; R J Seufert; M Schaffrath; K Pollow
Journal:  Fertil Steril       Date:  2001-01       Impact factor: 7.329

View more
  1 in total

1.  Luteinizing Hormone Levels Relate to the Unfavorable Pathology of Prostate Cancer.

Authors:  Se Young Choi; Byung Hoon Chi; Wonchul Lee; Bumjin Lim; Dalsan You; Choung-Soo Kim
Journal:  J Clin Med       Date:  2020-04-29       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.